We plan to begin the subject review in October 2019. We will perform this review to meet the annual reporting requirements of Public Law 105-277, “Office of National Drug Control Policy Reauthorization Act of 1998.” The objective of the review is to attest to whether the funds that the DoD obligated for the National Drug Control Program in FY 2019 are reported, in all material respects, in accordance with the Office of National Drug Control Policy Circular, “Accounting of Drug Control Funding and Performance Summary,” May 8, 2018.